Likewise, Nair et al. [73] demonstrated that PUR003 (inhaled cationic airway lining modulator (iCALM)) significantly reduced the eotaxin-1 concentration in comparison to placebo group after allergen inhalation in asthma patients. This evidence concerns the gene CCL11 and asthma.